Introduction Although previously regarded as a children's disease, it is clear that atopic
dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with …

Nocturnal pruritus (NP) is a relatively common reason for dermatologic consultation. Its
pathophysiology is partially understood. Skin conditions such as atopic dermatitis, psoriasis …

Background Baricitinib is an oral, selective, reversible Janus kinase 1/2 inhibitor approved in
the European Union and Japan and under investigation in the United States for treatment of …

Objective: Sleep and circadian disturbance is highly comorbid with a range of psychological
disorders, especially major depressive disorder (MDD). In view of the complexity of sleep …

Background Patients with atopic dermatitis (AD) have heterogeneous clinical phenotypes,
including different combinations of itch and lesional severity. Little is known about the …

Background Sleep disturbance (SD) is an important part of the burden of atopic dermatitis
(AD), but patient‐reported outcomes that are easy to understand and interpret in the target …

Background Little is known about the measurement properties of Patient-Oriented Scoring
Atopic Dermatitis (PO-SCORAD) in adults with atopic dermatitis (AD). Even less is known …

Background Few outcome measures were validated for assessing depressive symptoms in
AD. Patient Health Questionnaire-9 (PHQ9) and the abridged PHQ2 are established patient …

Assessment of atopic dermatitis (AD) severity is essential for therapeutic decision making
and monitoring treatment progress. However, there are a myriad of clinical measurement …

Background: Several app-based studies share similar characteristics of a light touch
approach that recruit, enroll, and onboard via a smartphone app and attempt to minimize …